Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Michelson

Showing results (311-320 of 339) with videos related to

Pageof 34
Sort By:
Blood|May 13, 2015
Platelet geometry sensing spatially regulates α-granule secretion to enable matrix self-depositionYumiko Sakurai, Jennifer L Fitch-Tewfik, Yongzhi Qiu, et al.
Thrombosis and Haemostasis|June 30, 2011
Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44Andrew L Frelinger, Alan D Michelson, Stephen D Wiviott, et al.
Circulation|January 16, 2008
Dosing of clopidogrel for platelet inhibition in infants and young children: primary results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) trialJennifer S Li, Eric Yow, Katherine Y Berezny, et al.
American Heart Journal|February 22, 2003
Quantification of abciximab-induced platelet inhibition is assay dependent: a comparative study in patients undergoing percutaneous coronary interventionMark I Furman, Dean J Kereiakes, Lori A Krueger, et al.
Journal of Thrombosis and Haemostasis : JTH|April 12, 2013
Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTHM Cattaneo, C Cerletti, P Harrison, et al.
Journal of Clinical Pharmacology|September 15, 2021
Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE StudyPeijuan Zhu, Stefan Willmann, Wangda Zhou, et al.
Biomedical Microdevices|July 29, 2016
Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endotheliumAbhishek Jain, Andries D van der Meer, Anne-Laure Papa, et al.
BMJ Open|January 21, 2014
Point-of-care assessment of platelet reactivity in the emergency department may facilitate rapid rule-out of acute coronary syndromes: a prospective cohort pilot feasibility studyChad E Darling, Javier A Sala Mercado, Walter Quiroga-Castro, et al.
American Heart Journal|October 31, 2001
Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximabM I Furman, D J Kereiakes, L A Krueger, et al.
Journal of the American Heart Association|September 24, 2021
Thromboprophylaxis for Children Post-Fontan Procedure: Insights From the UNIVERSE StudyBrian W McCrindle, Alan D Michelson, Andrew H Van Bergen, et al.
Pageof 34

Showing results (311-320 of 339) with videos related to

Sort By:
Pageof 34
Blood|May 13, 2015
Platelet geometry sensing spatially regulates α-granule secretion to enable matrix self-depositionYumiko Sakurai, Jennifer L Fitch-Tewfik, Yongzhi Qiu, et al.
Thrombosis and Haemostasis|June 30, 2011
Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44Andrew L Frelinger, Alan D Michelson, Stephen D Wiviott, et al.
Circulation|January 16, 2008
Dosing of clopidogrel for platelet inhibition in infants and young children: primary results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) trialJennifer S Li, Eric Yow, Katherine Y Berezny, et al.
American Heart Journal|February 22, 2003
Quantification of abciximab-induced platelet inhibition is assay dependent: a comparative study in patients undergoing percutaneous coronary interventionMark I Furman, Dean J Kereiakes, Lori A Krueger, et al.
Journal of Thrombosis and Haemostasis : JTH|April 12, 2013
Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTHM Cattaneo, C Cerletti, P Harrison, et al.
Journal of Clinical Pharmacology|September 15, 2021
Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE StudyPeijuan Zhu, Stefan Willmann, Wangda Zhou, et al.
Biomedical Microdevices|July 29, 2016
Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endotheliumAbhishek Jain, Andries D van der Meer, Anne-Laure Papa, et al.
BMJ Open|January 21, 2014
Point-of-care assessment of platelet reactivity in the emergency department may facilitate rapid rule-out of acute coronary syndromes: a prospective cohort pilot feasibility studyChad E Darling, Javier A Sala Mercado, Walter Quiroga-Castro, et al.
American Heart Journal|October 31, 2001
Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximabM I Furman, D J Kereiakes, L A Krueger, et al.
Journal of the American Heart Association|September 24, 2021
Thromboprophylaxis for Children Post-Fontan Procedure: Insights From the UNIVERSE StudyBrian W McCrindle, Alan D Michelson, Andrew H Van Bergen, et al.
Pageof 34